1. Home
  2. PRTC vs BAND Comparison

PRTC vs BAND Comparison

Compare PRTC & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • BAND
  • Stock Information
  • Founded
  • PRTC 2015
  • BAND 2000
  • Country
  • PRTC United States
  • BAND United States
  • Employees
  • PRTC N/A
  • BAND N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • PRTC Health Care
  • BAND Technology
  • Exchange
  • PRTC Nasdaq
  • BAND Nasdaq
  • Market Cap
  • PRTC 414.6M
  • BAND 358.3M
  • IPO Year
  • PRTC N/A
  • BAND 2017
  • Fundamental
  • Price
  • PRTC $16.78
  • BAND $14.07
  • Analyst Decision
  • PRTC Buy
  • BAND Hold
  • Analyst Count
  • PRTC 1
  • BAND 5
  • Target Price
  • PRTC $45.00
  • BAND $21.00
  • AVG Volume (30 Days)
  • PRTC 2.5K
  • BAND 270.0K
  • Earning Date
  • PRTC 04-30-2025
  • BAND 05-07-2025
  • Dividend Yield
  • PRTC N/A
  • BAND N/A
  • EPS Growth
  • PRTC N/A
  • BAND N/A
  • EPS
  • PRTC 0.21
  • BAND N/A
  • Revenue
  • PRTC $4,828,000.00
  • BAND $751,695,000.00
  • Revenue This Year
  • PRTC $35.98
  • BAND $1.59
  • Revenue Next Year
  • PRTC $115.38
  • BAND $13.79
  • P/E Ratio
  • PRTC $7.47
  • BAND N/A
  • Revenue Growth
  • PRTC 44.98
  • BAND 18.51
  • 52 Week Low
  • PRTC $13.30
  • BAND $11.33
  • 52 Week High
  • PRTC $32.98
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 45.09
  • BAND 61.76
  • Support Level
  • PRTC $17.41
  • BAND $11.93
  • Resistance Level
  • PRTC $17.55
  • BAND $12.72
  • Average True Range (ATR)
  • PRTC 0.46
  • BAND 0.46
  • MACD
  • PRTC 0.01
  • BAND 0.30
  • Stochastic Oscillator
  • PRTC 40.40
  • BAND 91.13

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: